Dr. Krystin Brandi discusses PRH’s response to the recent SCOTUS hearing on a challenge to 2016 and 2021 changes made by the FDA in how mifepristone is prescribed, which threatens access to medication abortion — and the wider threat to reproductive rights overall.
Brandi is also a complex family planning specialist who provides abortion care in New Jersey.
